Cargando…

Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208392/
https://www.ncbi.nlm.nih.gov/pubmed/35756182
http://dx.doi.org/10.4103/2666-2345.275504
_version_ 1784729730110455808
collection PubMed
description
format Online
Article
Text
id pubmed-9208392
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-92083922022-06-23 Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy J Immunother Precis Oncol Industry News Wolters Kluwer - Medknow 2020-03-31 /pmc/articles/PMC9208392/ /pubmed/35756182 http://dx.doi.org/10.4103/2666-2345.275504 Text en © 2020 Journal of Immunotherapy and Precision Oncology | Published by Wolters Kluwer - Medknow https://creativecommons.org/licenses/by/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (https://creativecommons.org/licenses/by/4.0/) , which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Industry News
Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title_full Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title_fullStr Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title_full_unstemmed Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title_short Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy
title_sort finding t-cure: a ceo's vision for the future of adoptive cell immunotherapy
topic Industry News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208392/
https://www.ncbi.nlm.nih.gov/pubmed/35756182
http://dx.doi.org/10.4103/2666-2345.275504